erlotinib eg 25 mg film-coat. tabl.
eg sa-nv - erlotinib hydrochloride 27,32 mg - eq. erlotinib 25 mg - film-coated tablet - 25 mg - erlotinib hydrochloride 27.32 mg - erlotinib
erlotinib eg 50 mg film-coat. tabl.
eg sa-nv - erlotinib hydrochloride 54,63 mg - eq. erlotinib 50 mg - film-coated tablet - 50 mg - erlotinib hydrochloride 54.63 mg - erlotinib
erlotinib eg 100 mg film-coat. tabl.
eg sa-nv - erlotinib hydrochloride 109,27 mg - eq. erlotinib 100 mg - film-coated tablet - 100 mg - erlotinib hydrochloride 109.27 mg - erlotinib
erlotinib eg 150 mg film-coat. tabl.
eg sa-nv - erlotinib hydrochloride 163,9 mg - eq. erlotinib 150 mg - film-coated tablet - 150 mg - erlotinib hydrochloride 163.9 mg - erlotinib
tarceva 25 mg film-coated tablet
roche - erlotinib - film-coated tablet - 25 mg
tarceva 100 mg film-coated tablet
roche - erlotinib - film-coated tablet - 100 mg
tarceva 150 mg film-coated tablet
roche, saudi arabia - erlotinib - film-coated tablet - 150 mg
pulectus 100 mg film coated tablet
hikma pharmaceuticals plc, jordan - erlotinib - film-coated tablet - 100 mg
pulectus 150 mg film coated tablet
hikma pharmaceuticals plc, jordan - erlotinib - film-coated tablet - 150 mg
erlotinib pharmascience 100 mg film coated tablets
pharmascience international ltd lampousas 1, 1095 nicosia , cyprus - erlotinib hydrochloride - film-coated tablet - erlotinib hydrochloride 100 mg - antineoplastic agents